EcoDrugPlus

Proteasome 26s Subunit, Non-Atpase 8

Ensembl ID : ENSGACG00000013044
Gene Symbol: PSMD8
1 Cross references
213 Possible Orthologues:

Protein Arginine Methyltransferase 5

Ensembl ID : ENSGACG00000014212
Gene Symbol: PRMT5
1 Cross references
199 Possible Orthologues:

Protein Kinase C Beta

Ensembl ID : ENSGACG00000014351
Gene Symbol: PRKCB
2 Cross references
213 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSGACG00000009511
Gene Symbol: PRKCD
1 Cross references
204 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSGACG00000002801
Gene Symbol: PRKCE
1 Cross references
250 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSGACG00000011409
Gene Symbol: PRKCE
1 Cross references
259 Possible Orthologues:

Protein Kinase C, Alpha, A

Ensembl ID : ENSGACG00000018519
Gene Symbol: PRKCAA
1 Cross references
212 Possible Orthologues:

Protein Kinase C, Beta A

Ensembl ID : ENSGACG00000016775
Gene Symbol: PRKCBA
1 Cross references
205 Possible Orthologues:

Protein Kinase C, Delta A

Ensembl ID : ENSGACG00000000771
Gene Symbol: PRKCDA
1 Cross references
206 Possible Orthologues:

Protein Kinase C, Eta, A

Ensembl ID : ENSGACG00000008506
Gene Symbol: PRKCHA
1 Cross references
223 Possible Orthologues:

Protein Kinase C, Theta

Ensembl ID : ENSGACG00000020094
Gene Symbol: PRKCQ
1 Cross references
205 Possible Orthologues:

Protein Kinase C, Zeta

Ensembl ID : ENSGACG00000013018
Gene Symbol: PRKCZ
1 Cross references
205 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).